Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia

NCT01728064 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich's Ataxia

Interventions

DRUG: Placebo
DRUG: EPI-743 400 mg
DRUG: EPI-743 200 mg

Sponsor

PTC Therapeutics